Skip to main content

Find Clinical Trials

Clinical trial condition

Ebola

Explore clinical trials studying Ebola. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Ebola trial results

Completed

Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia

NCT06811129

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +10 more
Locations: John F. Kennedy Medical Center Monrovia, Liberia

View Trial Details

Completed

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

NCT03031912

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: CHUM Montreal, Quebec, Canada

View Trial Details

Completed

A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants

NCT04228783

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Coastal Clinical Research, Inc Mobile, Alabama, United States

Clinical Research Consortium, an AMR company Tempe, Arizona, United States

Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States

The Center For Pharmaceutical Research Kansas City, Missouri, United States

View Trial Details

Completed

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

NCT05284097

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +8 more
Locations: EBOVAC Kambia 1 clinic Kambia, Sierra Leone

View Trial Details

Completed

A Study of a New Vaccine Against Two Types of Ebola

NCT05079750

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom

View Trial Details

Completed

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

NCT05064956

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: KAVI - Institute of Clinical Research Nairobi, Kenya

MRC/UVRI and LSHTM Uganda Research Unit Masaka, Buganda, Uganda

View Trial Details

Completed

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

NCT02818582

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Partnership of Clinical Research in Guinea (PREGUI) / Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah Forécariah, Maferinyah, Guinea

JFK Hospital Partnership for Research for Vaccines and Infectious Diseases in Liberia (PREVAIL) Monrovia, Liberia

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

NCT02370589

Conditions: Ebola, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Q-Pharm Pty Ltd. Brisbane, Queensland, Australia

Nucleus Network Melbourne, Victoria, Australia

Linear Clinical Research Nedlands, Western Australia, Australia

View Trial Details

Completed

Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy

NCT04385719

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +19 more
Locations: Infectious Diseases Institute Kampala, Uganda

View Trial Details

Completed

A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

NCT02240875

Conditions: Ebola, Ebola Zaire, Filoviridae Infections, +6 more
Locations: Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford Oxford, Oxfordshire, United Kingdom

View Trial Details